Previous studies [151, 152] have shown that TF on the surface of tumor-derived EVs is associated with platelet-activated aggregation and thrombosis and that EV-activated platelets can also be driven by TF-independent pathways, illustrating the complexity of the mechanism of tumor EV-induced platelet activation. The gene discussed is TF; the disease is neoplasm.